INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹288 Cr | ₹-66 Cr | ₹333 Cr | ₹233 Cr | ₹-132 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDEGENE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹288 Cr |
Mar2024 | ₹-66 Cr |
Mar2023 | ₹333 Cr |
Mar2022 | ₹233 Cr |
Mar2021 | ₹-132 Cr |
How is Cash Flow from Financing Activities of INDEGENE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹288 Cr | Positive | |
Mar2024 | ₹-66 Cr | Negative | |
Mar2023 | ₹333 Cr | 42.67 | |
Mar2022 | ₹233 Cr | Positive | |
Mar2021 | ₹-132 Cr | - |
Compare Cash Flow from Financing Activities of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,332.8 Cr | -1.1% | -3.4% | -4.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | -1.1% |
-3.4% |
-4.1% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses